Icecure medical announces receipt of nasdaq minimum bid price notification

Caesarea, israel , july 19, 2024 /prnewswire/ -- icecure medical ltd. (nasdaq: iccm) (the "company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that it has received a written notice (the "notice") from nasdaq stock market llc ("nasdaq") indicating that the company is not in compliance with the minimum bid price requirement for continued listing set forth in nasdaq listing rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.
NDAQ Ratings Summary
NDAQ Quant Ranking